Our aim is to identify molecular mechanisms underlying infections to find new strategies to treat disease.  This includes research on human bacterial pathogens, economically important animal pathogens and model organisms and the development of new approaches to fight Anti-microbial Resistance (AMR).

Principal Investigators:

  • Max Baldassarre (Actin cytoskeleton, Bacterial infections, Membrane trafficking, Integrins)
  • Karolin Hijazi (Antimicrobial resistance, Staphylococcus, Host-microbiome interactions, HIV-1)
  • Deborah Lockhart (Medical microbiology, Antimicrobial, Mycology, Epidemiology, Clinical)
  • Alexander Lorenz (Candida auris, Schizosaccharomyces pombe, Genetics)
  • Donna MacCallum (Candida albicans, Virulence, Infection)
  • Samantha Miller (Bacterial Membrane Proteins)
  • Carol Munro (Candida albicans, cell wall, chitin)
  • Soumya Palliyil  (Anti-infective biologics, AMR diagnostics and therapeutics, Recombinant antibody technology)
  • Fiona Rudkin (Candida albicans, Phagocytosis, Macrophages)
  • Stefania Spanò (Bacterial infections, Antimicrobial mechanisms, Host-defence)
  • Ian Stansfield (Ribosomes, Transfer RNA, Codon)
  • Pieter van West (Aquaculture, Oomycetes, Effectors & Infection processes, Fish vaccination)